Medical Data Vision, Jan-Mar (1Q) Ordinary Profit Decreases by 9%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon May 12, 2025 3:30 pm JST Earnings

3902 Medical Data Vision Co.,Ltd. 【J-GAAP】

Earnings Report

Medical Data Vision Co.,Ltd. <3902> [TSE Prime] announced its financial results after the market closed on May 12th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) decreased 9.1% from the same period last year to 0.02 billion yen. The progress rate toward the full-year plan of 2.5 billion yen was 0.8%, also falling below the five-year average of 24.9%.

In the most recent three-month period, from January to March (1Q), the operating profit margin worsened from 3.8% in the same period last year to 1.1%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Mar, 2023	1,559	423	424	275	7.2	60.6	May 11, 2023	J-GAAP
Jan - Mar, 2024	1,388	53	22	-15	-0.4	ー	May 13, 2024	J-GAAP
Jan - Mar, 2025	1,532	17	20	12	0.3	ー	May 12, 2025	J-GAAP
YoY	+10.4%	-67.9%	-9.1%	－	－

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2024	2,780	26	-32	-86	-2.3	0	Aug 8, 2024	J-GAAP
Jan - Jun, 2025 Guidance	ー	ー	ー	ー	－	0	Feb 10, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	6,419	1,770	1,700	979	25.6	6.50	Feb 13, 2024	J-GAAP
Dec, 2024	5,906	3	-509	-791	-20.7	6.50	Feb 10, 2025	J-GAAP
Dec, 2025 Guidance	9,000	2,600	2,500	1,650	43.6	9	Feb 10, 2025	J-GAAP
YoY	+52.4%	+86,566.7%	－	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	1,388	53	22	-15	-0.4	3.8	May 13, 2024	J-GAAP
Apr - Jun, 2024	1,392	-27	-54	-71	-1.9	-1.9	Aug 8, 2024	J-GAAP
Jul - Sep, 2024	1,345	-166	-197	-228	-6.0	-12.3	Nov 11, 2024	J-GAAP
Oct - Dec, 2024	1,781	143	-280	-477	-12.5	8.0	Feb 10, 2025	J-GAAP
Jan - Mar, 2025	1,532	17	20	12	0.3	1.1	May 12, 2025	J-GAAP
YoY	+10.4%	-67.9%	-9.1%	－	－